vs
Side-by-side financial comparison of ELECTRO SENSORS INC (ELSE) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
ELECTRO SENSORS INC is the larger business by last-quarter revenue ($2.8M vs $2.2M, roughly 1.2× Instil Bio, Inc.). ELECTRO SENSORS INC runs the higher net margin — 3.7% vs -365.3%, a 369.1% gap on every dollar of revenue. On growth, ELECTRO SENSORS INC posted the faster year-over-year revenue change (14.8% vs -19.2%).
Polar Electro Oy is a Finnish manufacturer of sports training computers, particularly known for developing the world's first wireless heart rate monitor.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
ELSE vs TIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.8M | $2.2M |
| Net Profit | $103.0K | $-8.2M |
| Gross Margin | 50.3% | — |
| Operating Margin | -0.3% | -426.3% |
| Net Margin | 3.7% | -365.3% |
| Revenue YoY | 14.8% | -19.2% |
| Net Profit YoY | -48.8% | 31.1% |
| EPS (diluted) | $0.03 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.8M | $2.2M | ||
| Q3 25 | $2.7M | $2.2M | ||
| Q2 25 | $2.4M | $2.2M | ||
| Q1 25 | $2.2M | $2.2M | ||
| Q4 24 | $2.4M | $2.8M | ||
| Q3 24 | $2.5M | $1.5M | ||
| Q2 24 | $2.2M | $0 | ||
| Q1 24 | $2.2M | $0 |
| Q4 25 | $103.0K | $-8.2M | ||
| Q3 25 | $208.0K | $-13.6M | ||
| Q2 25 | $59.0K | $-21.4M | ||
| Q1 25 | $-64.0K | $-28.2M | ||
| Q4 24 | $201.0K | $-11.9M | ||
| Q3 24 | $238.0K | $-23.0M | ||
| Q2 24 | $-4.0K | $-14.9M | ||
| Q1 24 | $11.0K | $-24.3M |
| Q4 25 | 50.3% | — | ||
| Q3 25 | 53.1% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 49.6% | — | ||
| Q3 24 | 50.4% | — | ||
| Q2 24 | 47.2% | — | ||
| Q1 24 | 48.1% | — |
| Q4 25 | -0.3% | -426.3% | ||
| Q3 25 | 6.6% | -670.0% | ||
| Q2 25 | -0.1% | -1045.5% | ||
| Q1 25 | -7.5% | -1363.2% | ||
| Q4 24 | 1.3% | -426.1% | ||
| Q3 24 | 6.9% | -1582.8% | ||
| Q2 24 | -4.8% | — | ||
| Q1 24 | -4.5% | — |
| Q4 25 | 3.7% | -365.3% | ||
| Q3 25 | 7.6% | -606.0% | ||
| Q2 25 | 2.5% | -954.2% | ||
| Q1 25 | -2.9% | -1257.8% | ||
| Q4 24 | 8.4% | -428.8% | ||
| Q3 24 | 9.5% | -1541.9% | ||
| Q2 24 | -0.2% | — | ||
| Q1 24 | 0.5% | — |
| Q4 25 | $0.03 | $-1.13 | ||
| Q3 25 | $0.06 | $-2.01 | ||
| Q2 25 | $0.02 | $-3.24 | ||
| Q1 25 | $-0.02 | $-4.32 | ||
| Q4 24 | $0.06 | $-1.82 | ||
| Q3 24 | $0.07 | $-3.54 | ||
| Q2 24 | $0.00 | $-2.29 | ||
| Q1 24 | $0.00 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.6M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $14.8M | $113.9M |
| Total Assets | $15.7M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.6M | $6.6M | ||
| Q3 25 | $10.6M | $5.8M | ||
| Q2 25 | $10.2M | $7.7M | ||
| Q1 25 | $10.0M | $15.4M | ||
| Q4 24 | $10.0M | $8.8M | ||
| Q3 24 | $10.3M | $6.7M | ||
| Q2 24 | $9.9M | $6.8M | ||
| Q1 24 | $10.1M | $5.5M |
| Q4 25 | $14.8M | $113.9M | ||
| Q3 25 | $14.7M | $120.4M | ||
| Q2 25 | $14.4M | $131.7M | ||
| Q1 25 | $14.3M | $144.9M | ||
| Q4 24 | $14.3M | $169.4M | ||
| Q3 24 | $14.1M | $176.3M | ||
| Q2 24 | $13.8M | $195.0M | ||
| Q1 24 | $13.8M | $205.8M |
| Q4 25 | $15.7M | $203.5M | ||
| Q3 25 | $15.7M | $211.8M | ||
| Q2 25 | $15.2M | $231.0M | ||
| Q1 25 | $15.1M | $237.4M | ||
| Q4 24 | $14.9M | $263.6M | ||
| Q3 24 | $15.0M | $272.6M | ||
| Q2 24 | $14.5M | $294.3M | ||
| Q1 24 | $14.5M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0K | $-7.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.0K | $-7.1M | ||
| Q3 25 | $395.0K | $-10.6M | ||
| Q2 25 | $277.0K | $-14.8M | ||
| Q1 25 | $-30.0K | $-4.2M | ||
| Q4 24 | $-277.0K | $-10.6M | ||
| Q3 24 | $362.0K | $-20.1M | ||
| Q2 24 | $-158.0K | $-10.6M | ||
| Q1 24 | $202.0K | $-14.4M |
| Q4 25 | — | — | ||
| Q3 25 | $389.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-298.0K | — | ||
| Q3 24 | $358.0K | — | ||
| Q2 24 | $-184.0K | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -12.4% | — | ||
| Q3 24 | 14.3% | — | ||
| Q2 24 | -8.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | 0.19× | — | ||
| Q3 25 | 1.90× | — | ||
| Q2 25 | 4.69× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -1.38× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 18.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
